Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. - Wikidata - awgldk - TriplyDB

Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.

Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.

http://www.wikidata.org/entity/Q33897273

about

The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors Oocyte polarized light microscopy, assay of specific follicular fluid metabolites, and gene expression in cumulus cells as different approaches to predict fertilization efficiency after ICSI.Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.Prediagnostic circulating anti-Müllerian hormone concentrations are not associated with prostate cancer risk Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.Regulation of gonadotropin gene expression by Mullerian inhibiting substance.Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.A single base pair mutation encoding a premature stop codon in the MIS type II receptor is responsible for canine persistent Müllerian duct syndrome.Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2.Vitamin D regulates anti-Mullerian hormone expression in granulosa cells of the hen.

P2860

Q24306670-E126676D-F2ED-48A0-B043-B05026BD435C Q28511212-3DFCAC40-969B-467B-95E6-F3AFDFF341D1 Q33827655-9C0BBACE-0D7E-437B-81A3-FE34B51C2BA9 Q33927553-0FF977E7-C71C-4AD7-BEF3-DD1BB447E216 Q34246272-BB2D4938-FB45-4C38-9C7A-4F2E37CBDD91 Q34434627-37F04207-8B78-4D6F-B5F6-960E6610F815 Q34458280-ABA6AC65-2615-4942-BE57-DBBD416DA9E9 Q34789719-F030B527-9AC9-402F-AF6B-13D95E08FA07 Q35234562-574194EE-6E26-4789-B22F-944D3D90E5B8 Q35768666-5609FC06-8E56-4391-9750-68F39B30401F Q36214988-A54C666C-B780-4E92-AAAE-5278A2FB54CD Q36435768-5C266A5C-ED7E-4C92-9001-7CDE7EE2965B Q36637142-64A0E3CA-8664-4EA3-8449-74CACD40A2CE Q36995723-92AAEBC8-2BC6-4F6C-838D-8211D0BB51C7 Q37136953-1452CCE3-AD4D-47E9-8B96-AF518720AF51 Q37707380-2CFC517D-0340-488A-BF9B-2DE995606A71 Q39393122-70EA0C7F-9079-4E6F-91F3-1A14F8112A6A Q39542130-9E3BE7EF-2BD8-4428-9991-E6DAE5A421F3 Q40208275-4D967BFC-115A-4D9C-8195-54CDB14F1F36 Q51375178-8CAF890D-488C-4D57-9FFF-1F869679C8E4

P2860

Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.

http://www.wikidata.org/entity/Q33897273

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@ast

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@en

type

label

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@ast

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@en

prefLabel

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@ast

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@en

P1433

Q33897273-DFF8E739-9326-4657-8B88-CEF315A87254

P1476

Q33897273-21C529EB-8548-4DEF-AF91-A7A3B9FD32B6

P2093

Q33897273-319AF367-1DE5-4AB3-A6B3-A6D0801A569F

Q33897273-3EE209E1-FFC9-4546-9D95-BD51CE709517

Q33897273-4AC6974A-4804-4DAB-BF44-691873E9B31F

Q33897273-4AEEF280-5F3B-4938-A180-EA0293F64ACE

Q33897273-5A0F7FDB-5993-4C88-AE1C-707C4E5B8950

Q33897273-795FB7CB-10A9-4165-B396-97DA6E0FFEBE

Q33897273-854A773B-54EF-49A3-9DE4-4966E307038F

Q33897273-CD580A6E-6569-41F7-A0B2-DBAFA762812B

Q33897273-E7773081-608B-4F04-8282-05201BB3C0F2

P2860

Q33897273-014AA34E-CF3A-4318-9245-5C3D87829C7D

Q33897273-042DBFB2-880A-4F24-89A2-486D568CB830

Q33897273-058E0F3C-60B6-4B3E-A3AF-36CC6272F5CA

Q33897273-0A72DD22-31EB-40FE-AB20-3BD514595953

Q33897273-0B2710B9-28C0-4353-BFF4-0DE7AB18A02C

Q33897273-27274C2D-5302-446E-95D3-75D499A6FD0B

Q33897273-33513852-9117-4D99-B6EA-26E867558E75

Q33897273-381476FF-B2E1-4947-BC0A-17A6243B0435

Q33897273-3F031E63-BFF8-40F1-A3D3-698E18A93973

Q33897273-44606899-AB7E-4519-88D5-73B9F634BE1F

P304

Q33897273-480A066B-1CAB-4054-A5EF-23DE136F77D1

P31

Q33897273-9A8AA20C-62A0-4F66-B1AC-4842916A8A03

P356

Q33897273-88CD8B30-71B9-49D4-BE9E-9A1A699A4C5E

P407

Q33897273-870C26C8-507D-4EB6-929E-D67765B7317F

P433

Q33897273-71166FF3-992E-4802-BFFB-9D9A49B761FD

P478

Q33897273-96CB8C05-0620-439A-853F-BBA49E9264AE

P577

Q33897273-AD92F699-B45F-4790-9373-D8165025F0CD

P5875

Q33897273-DC468652-A1C4-47A9-A2CF-949A0C926810

P698

Q33897273-5EF6FFA4-4B62-446A-8AAA-7F28912C3709

P932

Q33897273-4A540734-6128-4B59-A00B-F5AFD9106420

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mullerian-inhibiting substance ...... prostate in vitro and in vivo.

@en

P2093

Antonia E Stephen

http://www.w3.org/2001/XMLSchema#string

David T MacLaughlin

http://www.w3.org/2001/XMLSchema#string

Dorry L Segev

http://www.w3.org/2001/XMLSchema#string

Jennifer L Carey

http://www.w3.org/2001/XMLSchema#string

Makiko Hoshiya

http://www.w3.org/2001/XMLSchema#string

Patricia K Donahoe

http://www.w3.org/2001/XMLSchema#string

Shyamala Maheswaran

http://www.w3.org/2001/XMLSchema#string

Trinh T Tran

http://www.w3.org/2001/XMLSchema#string

Yasunori Hoshiya

http://www.w3.org/2001/XMLSchema#string

P2860

Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues

TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling

Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo

Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.

Control of apoptosis by Rel/NF-kappaB transcription factors.

SMAD3 represses androgen receptor-mediated transcription.

P304

239-244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.221599298

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11583646

http://www.w3.org/2001/XMLSchema#string

P698

11773638

http://www.w3.org/2001/XMLSchema#string

P932

117545

http://www.w3.org/2001/XMLSchema#string